Abscess
☆ AI Dermatology — Free Service
Liphethong tsa 2022 Stiftung Warentest tse tsoang Jeremane, khotsofalo ea bareki ka ModelDerm e ne e le tlase hanyane ho feta lipuisano tse lefelloang tsa telemedicine.
Liphethong tsa 2022 Stiftung Warentest tse tsoang Jeremane, khotsofalo ea bareki ka ModelDerm e ne e le tlase hanyane ho feta lipuisano tse lefelloang tsa telemedicine.
inflamed epidermal cyst. Letheba le letšo le amana le cyst e ka tlaase.
Mofuta o matla oa Abscess o ka siea lebali. Erythema e fokolang e potolohileng leqeba e bontša hore tšoaetso e boemong ba ho rarolla.
Abscess ― matsatsi a mahlano ka mor'a ho seha le ho ntša metsi
relevance score : -100.0%
ReferencesBatho ba bangata ba ea likamoreng tsa maemo a tšohanyetso bakeng sa mafu a letlalo a bakoang ke bakteria. Staphylococcus aureus ke kokoana‑hloko e ka sehloohong e bakang mafu ana, 'me ho ntse ho thatafala ho alafa ka lebaka la ho hlaha ha community‑associated methicillin‑resistant Staphylococcus aureus (MRSA).
Acute bacterial skin and skin-structure infections are a common reason for seeking care at acute healthcare facilities, including emergency departments. Staphylococcus aureus is the most common organism associated with these infections, and the emergence of community-associated methicillin-resistant Staphylococcus aureus (MRSA) has represented a considerable challenge in their treatment.
Acute bacterial skin and skin-structure infections are a common reason for seeking care at acute healthcare facilities, including emergency departments. Staphylococcus aureus is the most common organism associated with these infections, and the emergence of community-associated methicillin-resistant Staphylococcus aureus (MRSA) has represented a considerable challenge in their treatment.
Staphylococcus aureus e ka aroloa ka mefuta e 'meli ho latela karabelo ea bona ho lithibela-mafu: methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA). Lilemong tse mashome a seng makae tse fetileng, ka lebaka la ho iphetola ha bakteria le tšebeliso e feteletseng ea lithibela-mafu, kanyetso ea S. aureus (Staphylococcus aureus) ho lithethefatsi e ntse e eketseha, e leng se lebisang keketsehong ea lefats'e ea MRSA # litekanyetso tsa ts'oaetso.
According to the sensitivity to antibiotic drugs, S. aureus can be divided into methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA). In recent decades, due to the evolution of bacteria and the abuse of antibiotics, the drug resistance of S. aureus has gradually increased, the infection rate of MRSA has increased worldwide.
According to the sensitivity to antibiotic drugs, S. aureus can be divided into methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA). In recent decades, due to the evolution of bacteria and the abuse of antibiotics, the drug resistance of S. aureus has gradually increased, the infection rate of MRSA has increased worldwide.
To review the salient features of the management of severe skin and soft tissue infections (SSTIs), including toxic shock syndrome, myonecrosis/gas gangrene, and necrotizing fasciitis.
Hangata li bakoa ke tšoaetso ea baktheria (bacterial infection). Baktheria e atileng haholo e teng ke Staphylococcus aureus e hananang le methicillin (MRSA). Hangata ho hlahlojoa ha abscess ea letlalo (skin abscess) ho itšetlehile ka hore na le shebahala joang, ‘me ho tiisoa ka ho kgaola le ho ntša metsi (incision and drainage). Ho nka litšoantšo ka ultrasound ho ka ba molemo maemong ao tlhahlobo e sa hlakeheng. Libakeng tse pota‑potileng perianal, computer tomography (CT) e ka ’na ea ba ea bohlokoa ho sheba tšoaetso e tebileng.
Kalafo e tloaelehileng bakeng sa boholo ba letlalo kapa maqeba a linama tse bonolo ke ho kgaola le ho ntša metsi hangata e kopantsoe le lithethefatsi (antibiotics). Ho anya boladu ka nalele (needle) hangata ha hoa lekana.
Li‑abscesses tsa letlalo li tloaelehile ’me li atile haholo lilemong tsa morao tjena. Lintho tse kotsi li kenyelletsa tšebeliso ea lithethefatsi ka methapo (intravenous drug use), ‘me litekanyetso li tlalehoa li le holimo ho 65 % har’a basebelisi. Ka 2005 United States, batho ba limilione tse 3.2 ba ile ba ea lefu la tšohanyetso (emergency department) bakeng sa abscess. Australia, batho ba ka bang 13 000 ba ile ba kena sepetlele ka 2008 ka boemo bona.
○ Kalafo
Ho alafa li‑abscesses ka lithethefatsi tse rekisoang ntle le ngaka (over‑the‑counter medications) ho thata maemong a mangata. Haeba matšoao a kang feberu le serame a hlaha ‘meleng, ka kopo ikopanye le ngaka kapele kamoo ho ka khonehang.